Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Camp4 Therapeutics (CAMP) Net Margin: 2023-2025

Historic Net Margin for Camp4 Therapeutics (CAMP) over the last 1 years, with Sep 2025 value amounting to -1,663.90%.

  • Camp4 Therapeutics' Net Margin fell 2341229.00% to -1,663.90% in Q3 2025 from the same period last year, while for Sep 2025 it was -1,357.02%, marking a year-over-year change of. This contributed to the annual value of -7,943.40% for FY2024, which is 613974.00% up from last year.
  • Latest data reveals that Camp4 Therapeutics reported Net Margin of -1,663.90% as of Q3 2025, which was down 98.08% from -840.01% recorded in Q2 2025.
  • Camp4 Therapeutics' Net Margin's 5-year high stood at 21,748.39% during Q3 2024, with a 5-year trough of -3,341.71% in Q3 2023.
  • Its 3-year average for Net Margin is 4,008.35%, with a median of -1,458.28% in 2025.
  • Per our database at Business Quant, Camp4 Therapeutics' Net Margin skyrocketed by 2,509,010bps in 2024 and then crashed by 2,341,229bps in 2025.
  • Camp4 Therapeutics' Net Margin (Quarterly) stood at 15,650.60% in 2023, then plummeted by 1,768,726bps to -2,036.66% in 2024, then tumbled by 2,341,229bps to -1,663.90% in 2025.
  • Its last three reported values are -1,663.90% in Q3 2025, -840.01% for Q2 2025, and -1,458.28% during Q1 2025.